Allakos logo
Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price on May 14, 2025

Allakos Stock Forecast

ALLK's stock price has decreased by -73.02% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Allakos stock had an average target of $2.00, with a low estimate of $1.00 and a high estimate of $3.00.

Price Target: $2.00 (+507.72%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$1.00$2.00n/a$3.00
Change+203.86%+507.72%n/a+811.58%

Analyst Ratings

The average analyst rating for Allakos stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
from 7.55M
Revenue Next Year
n/a
EPS This Year
-0.62
from -1.30
EPS Next Year
-0.23
from -0.62
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
EPS
-3.10-5.01-5.06-2.14-1.30-0.62-0.23
No. Analysts
-----55

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-0.55-0.05
Avg-0.62-0.23
Low-0.74-0.32

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--